The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata

The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata

0 Umsagnir
0
Episode
425 of 1057
Lengd
25Mín.
Tungumál
enska
Gerð
Flokkur
Viðskiptabækur

Glen de Vries cofounded Medidata in 1999, offering SaaS-based clinical development solutions addressing the functioning of customers' clinical trials, and 20 years later the company - which he still leads - sold to Dassault Systemes for almost $6 billion. What a triumph, Glen! Thank you for joining the podcast. Listen in as Glen shares his unique and valuable perspective on the current state and potential futures for the data ecosystem in Life Sciences. Want to stay on the cutting edge of emerging data-driven technologies? Try out Emerj Plus: emerj.com/p1


Hlustaðu og lestu

Stígðu inn í heim af óteljandi sögum

  • Lestu og hlustaðu eins mikið og þú vilt
  • Þúsundir titla
  • Getur sagt upp hvenær sem er
  • Engin skuldbinding
is Device Banner Block 894x1036
Cover for The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata

Other podcasts you might like ...